Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	82.01	37.84	20.79
Graham Fair Price	51.83	5.05	3.32
PEG	-84.89	0.13	-0.88
Price/Book	-6.95	0.87	0.94
Price/Cash Flow	186.44	-102.66	35.84
Prices/Earnings	-59.12	16.54	40.47
Price/Sales	11.95	3.02	2.70
Price/FCF	186.44	-102.66	35.84
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.89	0.30	0.30
Operating Margin	1.98	0.05	0.05
ROA	128.82	< 0.005	< 0.005
ROE	< 0.005	0.01	127.63
ROIC	< 0.005	< 0.005	11.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	1.49	-97.93
Dividends QOQ	-0.60	1.38	130.23
EBIT QOQ	0.27	-0.15	-46.02
EPS QOQ	-0.46	1.25	170.45
FCF QOQ	-0.06	-1.33	-2089.83
Revenue QOQ	0.07	-0.16	129.93
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	93.71	112.95	20.53
Days Sales Outstanding (DSO)	99.16	117.56	18.56
Inventory Turnover	0.96	0.80	-17.03
Debt/Capitalization	0.18	0.18	-2.66
Quick Ratio	1.08	1.06	-1.86
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	9.20	9.26	0.63
Cash	3.15	3.06	-2.95
Capex	0.05	-0.28	479.55
Free Cash Flow	0.24	-0.08	-67.31
Revenue	3.20	2.68	-16.36
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.49	1.52	1.95
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.59	-4.92	-89.93
Naive Interpretation	Member

06 - Financial Health · Weak

Rating